Pasquale Persico
Rozzano, 20089, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS network.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 16, 2026
Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.
Journal: Journal of neuro-oncology
Published: January 08, 2026
Case study: Successful full-course chemotherapy administration in a liver transplant recipient diagnosed with central nervous system World Health Organization Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.
Journal: Neuro-oncology practice
Published: October 13, 2025
Primary mismatch repair deficiency and Lynch syndrome in adult diffuse gliomas: A call to action.
Journal: Cancer
Published: August 07, 2025
Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events.
Journal: Journal for immunotherapy of cancer
Published: March 07, 2025
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].
Journal: Cancer treatment reviews
Published: December 21, 2024
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.
Journal: Cancer treatment reviews
Published: September 23, 2024
Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study.
Journal: ESMO open
Published: February 20, 2024
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram.
Journal: Frontiers in immunology
Published: November 16, 2023
Brain metastases and next-generation anticancer therapies: a survival guide for clinicians.
Journal: Critical reviews in oncology/hematology
Published: September 04, 2023
Last Updated: 09/26/2026